Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The pivotal trials leading to FDA approval demonstrated reductions in visceral adipose tissue of approximately 15 to 20% over 26 weeks in HIV lipodystrophy patients, with continued reduction at 52 weeks
No Certificate of Analysis available Prices dramatically below market averages Unclear peptide sequences or synthesis methods Poor or absent storage condition information No established reputation or verifiable reviews Vague claims about purity without documentation Canadian Regulatory Context Health Canada regulates peptides differently than the United States FDA, though both agencies consider most research peptides outside approved pharmaceutical frameworks
,
A comprehensive review of 36 studies (1993-2024) confirms effects on growth factor upregulation, VEGF/VEGFR2 expression, and FAK-paxillin cell migration pathways
US$ 24.09
US$ 26.52
US$ 26.18
US$ 25.71
US$ 20.83
